CVS Health (CVS) Declares $0.55 Quarterly Dividend; 2.3% Yield

CVS Health (CVS) PT Raised to $118 at Truist Securities

December 10, 2021 7:32 AM EST

Truist Securities analyst David MacDonald raised the price target on CVS Health (NYSE: CVS) to $118.00 (from $112.00) while maintaining a Buy rating.... More

CVS Health (CVS) PT Raised to $114 at Cowen

December 10, 2021 7:19 AM EST

Cowen analyst Charles Rhyee raised the price target on CVS Health (NYSE: CVS) to $114.00 (from $103.00) while maintaining an Outperform rating.

The analyst commented, "We remain positive on CVS following the Analyst Day, as we're encouraged by the visibility toward low-double digit adj. EPS... More

CVS Health (CVS) PT Raised to $110 at Mizuho Securities

December 10, 2021 6:35 AM EST

Mizuho Securities analyst Ann Hynes raised the price target on CVS Health (NYSE: CVS) to $110.00 (from $105.00) while maintaining a Buy rating.... More

CVS Health (CVS) PT Raised to $115 at BofA Securities

December 10, 2021 6:27 AM EST

BofA Securities analyst Michael Cherny raised the price target on CVS Health (NYSE: CVS) to $115.00 (from $112.00) while maintaining a Buy rating.... More

Major U.S. retailers urge action by Congress on online stolen, counterfeit goods sales

December 9, 2021 9:54 AM EST

By David Shepardson

WASHINGTON (Reuters) -The chief executives of major U.S. retailers including Target, Home Depot, Kroger, CVS Health, Autozone and Best Buy on Thursday urged Congress to take action to address the online sale of stolen, counterfeit and dangerous consumer products.

The group called on Congress to crack down on anonymous online sales, citing the growing impact of organized retail crime.

"Retail establishments of all kinds have seen a significant uptick in... More

CVS Health sees fall in COVID-19 vaccine, testing revenue in 2022

December 9, 2021 7:12 AM EST

(Reuters) -Drugstore operator CVS Health Corp said on Thursday it expects revenue from COVID-19 vaccination and testing to decline significantly next year, after it forecast 2022 adjusted earnings largely below estimates.

Shares of CVS, however, were up 3.8% at $96.7 after it raised its 2021 profit forecast to $8.00 per share from prior estimate of $7.90 to $8.00, with the company seeing higher-than-expected COVID-19 vaccine and testing sale volumes in the fourth quarter.

Pharmacy chains like CVS have benefited from... More

CVS Health (CVS) to Raise Dividend for First Time in 5 Years in 2022, Sets $10B Stock Buyback

December 9, 2021 6:35 AM EST

With its guidance metrics just released, CVS Health (NYSE: CVS) announced that it will increase its yearly dividend by 10%, from $2.00 to $2.20, effective with the next dividend distribution on February 1, 2022. The company also has authorized a $10 billion share repurchase program, which will be used... More

CVS Health (CVS) Announces FY21 and FY22 Guidance, Raises Dividend and Approves $10B Buyback Plan

December 9, 2021 6:32 AM EST

(Updated - December 9, 2021 6:34 AM EST)

Today at its 2021 Investor Day, the CVS Health (NYSE: CVS) leadership team will present a strategy that capitalizes on the significant opportunity to make health care more convenient, personalized and affordable for consumers. Leaders will articulate how investing in high-growth areas of the business and introducing new health products, services and technologies will enhance shareholder value. The company will also provide greater visibility into its near- and long-term financial performance expectations.

"Now is the time to undertake our next major evolution and capitalize on our... More